DevelopingLegal

Connecticut Federal Court Preliminarily Approves $96.5 Million Generic Drug Settlement Fund

A Connecticut federal court preliminarily approved a plan splitting about $96.5 million among buyers of certain generic drugs bought between May 2009 and December 2019.

Why it matters

The story is a state-level enforcement outcome in the pharmaceutical sector, with no token, exchange, protocol or market asset named in the evidence, so its significance for crypto markets is limited. What it does show is multi-state litigation reaching a preliminary court-approved distribution stage and money moving back to consumers who bought specific generics over a decade-long window.

Key facts

A federal court in Connecticut gave preliminary approval to a plan splitting about $96.5 million from generic drug price-fixing settlements.

96,500,000 USDReported by The Daily Hodl

The settlement funds come from Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage's parent Emcure.

Reported by The Daily Hodl

A multistate coalition led by Michigan is running the claim process for the settlement money.

Reported by The Daily Hodl

Consumers who bought the covered generic drugs between May 2009 and December 2019 are invited to check eligibility and file a claim.

Reported by The Daily Hodl

Michigan Attorney General Dana Nessel said consumers who paid high generic prices are now entitled to compensation.

Reported by The Daily Hodl

The states have been pursuing the generic drug price-fixing cases since 2016.

Reported by The Daily Hodl

Eligible buyers can file at AGGenericDrugs.com, call 1-866-290-0182 or email the address listed in the article.

Reported by The Daily Hodl

What happened

The Daily Hodl reported that a federal court in Connecticut gave preliminary approval this month to a plan distributing about $96.5 million from settlements reached with Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage's parent Emcure over generic drug price-fixing. The outlet said a multistate coalition led by Michigan is administering the plan and that buyers of the listed generic drugs between May 2009 and December 2019 can check their eligibility and file a claim. Michigan Attorney General Dana Nessel said consumers who paid inflated prices are now entitled to compensation and called the settlements accountability for conspiring to raise drug prices, according to The Daily Hodl. The same outlet said the states have pursued the price-fixing cases since 2016. No second outlet in the desk's evidence set reports the approval, so the preliminary status, the amount and the covered period rest on The Daily Hodl alone, and the article does not state how much any individual buyer would receive or when payments would begin.

How the story developed

  1. First report

    First report by The Daily Hodl

    Americans Can File for a Share of $96,500,000 in Generic Drug Price-Fixing Settlements

    The Daily Hodl

  2. Update

    The Daily Hodl reports the court approval and consumer filing window

    The outlet reported that a Connecticut federal court gave preliminary approval to a plan splitting about $96.5 million and that buyers of listed generics from May 2009 to December 2019 can file.

    The Daily Hodl

  3. Update

    Preliminary approval of the settlement distribution plan

    The article places the ruling in the same month as its publication and does not give a specific court date, judge or docket number.

    The Daily Hodl

Affected entities

Original sources

PublisherReportRolePublished
The Daily Hodl
Crypto media
Americans Can File for a Share of $96,500,000 in Generic Drug Price-Fixing SettlementsOriginal